Characteristics of patient and family member respondents
| Characteristic (n, %) | Identifying priorities questionnaire (N=630) | Prioritisation questionnaire (N=218) |
| Gender | ||
| Male | 271 (43.0) | 86 (39.4) |
| Female | 353 (56.0) | 104 (47.7) |
| Non-binary | 2 (0.3) | 1 (0.5) |
| No response/prefer not to answer | 7 (1.1) | 27 (12.4) |
| Age | ||
| 18–39 | 147 (23.3) | 20 (10.5) |
| 40–59 | 269 (42.5) | 90 (47.1) |
| 60–69 | 141 (22.3) | 58 (30.4) |
| 70–79 | 63 (10.0) | 19 (9.9) |
| 80–89 | 10 (1.6) | 4 (2.1) |
| Missing | 3 (0.5) | 27 (12.4) |
| Ethnicity | ||
| Caucasian | 548 (86.6) | 176 (80.7) |
| Metis | 24 (3.8) | 10 (4.6) |
| South-East Asian | 18 (2.8) | 1 (0.5) |
| First Nations | 16 (2.5) | 3 (1.4) |
| Middle Eastern | 4 (0.6) | 1 (0.5) |
| Black | 2 (0.3) | 0 |
| Other | 17 (2.7) | |
| Missing | 4 (0.6) | |
| Respondent category | ||
| Diagnosed with OSA | 466 (73.9) | 196 (89.9) |
| On waiting list for assessment | 7 (1.1) | |
| Suspects OSA but has not sought evaluation | 27 (4.3) | |
| Family member of patient diagnosed with OSA | 94 (14.8) | 22 (10.1) |
| Family member of person with suspected OSA | 36 (5.7) | |
| Agricultural producers | 45 (7.2) | 13 (6.0) |
| Ever prescribed treatment of OSA | ||
| Yes | 566 (89.4) | NA |
| No | 62 (9.8) | |
| Missing | 5 (0.8) | |
| Currently using CPAP | ||
| Yes, 4 or more nights per week | 420 (66.4) | NA |
| Yes, 1–3 nights per week | 16 (2.5) | |
| Yes, intermittently | 52 (8.2) | |
| No | 141 (22.3) | |
| Missing | 4 (0.6) | |
| Duration of CPAP use Under 1 year | 49 (7.7) | NA |
| 1–5 years | 260 (41.1) | |
| 6–10 years | 93 (14.7) | |
| >10 years | 85 (13.4) | |
| Missing/NA | 146 (23.1) | |
| Reasons for going without treatment | NA | |
| Unsure where to go for assessment | 73 (11.5) | |
| Cost of equipment | 195 (30.8) | |
| Travel distance to assessment | 42 (6.6) | |
| On waiting list | 47 (4.7) | |
| Other reasons (free-text responses) | 340 (53.7) |
CPAP, continuous positive airway pressure; NA, not available; OSA, obstructive sleep apnoea.